EAM Investors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-66,422
| Closed | -$2.69M | – | 227 |
|
|
2025
Q1 | $2.69M | Buy |
+66,422
| New | +$2.69M | 0.46% | 112 |
|
|
2023
Q3 | – | Sell |
-50,856
| Closed | -$2.37M | – | 277 |
|
|
2023
Q2 | $2.37M | Buy |
50,856
+6,169
| +14% | +$288K | 0.44% | 86 |
|
|
2023
Q1 | $1.71M | Sell |
44,687
-8,825
| -16% | -$338K | 0.34% | 142 |
|
|
2022
Q4 | $2.93M | Sell |
53,512
-31,095
| -37% | -$1.7M | 0.61% | 41 |
|
|
2022
Q3 | $2.88M | Buy |
+84,607
| New | +$2.88M | 0.63% | 37 |
|
|
2020
Q4 | – | Sell |
-63,928
| Closed | -$1.97M | – | 295 |
|
|
2020
Q3 | $1.97M | Buy |
+63,928
| New | +$1.97M | 0.47% | 60 |
|